Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer

International Urology and Nephrology

Volumn 39, Issue 2, 2007, Pages 381-387

  Pertia, Ambrosi ^a   Nikoleishvili, David ^a   Trsintsadze, Omar ^a   Gogokhia, Nino ^b   Managadze, Laurent ^a   Chkhotua, Archil ^a  

^a A Tsulukidze National Centre of Urology   (Georgia)

^b State Medical Academy   (Georgia)

Author keywords

CDKI; Cell cycle; p27(Kip1); Renal cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PARTIAL NEPHRECTOMY; PREDICTION; PROTEIN EXPRESSION; RECURRENCE RISK; RISK ASSESSMENT; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 34447312829     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-9077-6     Document Type: Article

References (25)

1. Jemal A, Tiwari RC, Murray T et al (2004) Cancer statistics. CA Cancer J Clin 54:8-29
2. Lam JS, Shvarts O, Leppert JT et al (2005) Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853-1862
3. Kontak JA, Campbell SC (2003) Prognostic factors in renal cell carcinoma. Urol Clin North Am 30:467-481
4. Oosterwijk E (2005) Tumor markers for renal cell carcinoma. J Urol 173:2150-2155
5. Lam JS, Leppert JT, Figlin RA et al (2005) Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology 66(S5):1-9
6. de Kernion JB (2005) Reexamination of current staging for renal cell carcinoma. J Urol 173:680
7. Shvarts O, Lam JS, Kim HL et al (2005) Staging of renal cell carcinoma: current concepts. BJU Int 95:8-13
8. Kawamata N, Morosetti R, Miller CW et al (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55:2266-2269
9. Gizard F, Robillard R, Gervois P et al (2005) Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene. FEBS Lett 579:5535-5541
10. Galizia G, Ferraraccio F, Lieto E et al (2004) Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery. Dis Colon Rectum 47:1904-1914
11. Singhal S, Vachani A, Antin-Ozerkis D et al (2005) Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res 11:3974-3986
12. Revelos K, Petraki C, Gregorakis A et al (2005) p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. In Vivo 19:911-920
13. Dreher T, Zentgraf H, Abel U et al (2004) Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies. Virchows Arch 444:509-517
14. Langner C, von Wasielewski R, Ratschek M et al (2004) Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma. Urology 4:611-616
15. Strauss M, Lukas J, Bartek J et al (1995) Unrestricted cell cycling and cancer. Nat Med 1:1245-1246
16. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
17. Haitel A, Wiener HG, Neudert B et al (2001) Expression of the cell cycle proteins p21, p27 and pRb in clear renal cell carcinoma and their prognostic significance. Urology 58:477-481
18. Migita T, Oda Y, Naito S et al (2002) Low expression of p27 KIP1 is associated with tumor size and poor prognosis in patients with Renal Cell Carcinoma. Cancer 94:973-979
19. Hedberg Y, Davoodia E, Ljunberg B et al (2002) Cyclin E and p27 protein content in human renal cell carcinoma: Clinical outcome and associations with cyclin D. Int J Cancer 20:601-607
20. Hedberg Y, Ljungberg B, Roos G et al (2003) Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 88:1417-1422
21. Langner C, von Wasielewski R, Ratschek M et al (2004) Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique. Virchows Arch 445:631-636
22. Langner C, Rehak P, Ratschek M et al (2005) The pT1a and pT1b category subdivision in renal cell carcinoma: Is it reflected by differences in tumour biology? BJU Int 95:310-314
23. Guinan P, Sobin LH, Algaba F et al (1997) TNM staging of renal cell carcinoma: Workgroup No. 3-Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:992-993
24. Melk A, Scmidt BMW, Takeuchi O et al (2004) Expression of p16 INK4a and other cell cycle regulator and senescence associated genes in aging human kidneys. Kidney Int 65:510-520
25. von Schnakenburg C, Strehlau J, Ehrich J, Melk A (2002) Quantitative gene expression of TGF-beta1, IL-10, TNF-alpha and Fas Ligand in renal cortex and medulla. Nephrol Dial Transplant 17:573-579